MiMedx Group MDXG Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 81%-0.9pp | 82.6%-0.2pp | 82%-1.4pp | 81.5%-2.0pp | 81.9%-1.6pp | |
| Operating margin | 10.2%-5.1pp | 15.3%-1.6pp | 13.7%-4.8pp | 11.8%— | 15.3%— | |
| Net margin | 7.9%-3.5pp | 11.6%-0.6pp | 10.4%-15.4pp | 8.8%-17.3pp | 11.4%-10.3pp | |
| Returns | ||||||
| Return on equity | 13.8%— | 21.6%— | 19.4%— | 16.7%— | —— | |
| Return on invested capital | 26.6%— | 41.4%— | 34.9%— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 1.3×-0.1× | 1.4×0.0× | 1.4×-0.2× | 1.4×-0.3× | 1.4×-0.3× | |
| Liquidity | ||||||
| Current ratio | 5.4×+0.7× | 4.3×+0.1× | 4.4×+0.3× | 4.4×+0.5× | 4.7×+1.4× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×— | |
| Net debt / EBITDA | -2.8×-1.4× | -1.8×-0.6× | -1.9×-0.8× | -1.9×— | -1.4×— | |
| Per Share | ||||||
| Book value per share | $1.64+20.8% | $1.71+32.3% | $1.60+30.8% | $1.45+28.5% | $1.35+30.5% | |
| Valuation | ||||||
| Market capitalization | $567.48M-33.9% | $1B-29.1% | $1.03B+19.0% | $880.3M-13.9% | $1.12B-1.0% | |
| Price / earnings | 18.5×-2.9× | 20.6×-12.7× | 25.3×+15.5× | 27.4×+15.9× | 27.9×— | |
| Price / sales | 1.5×-1.0× | 2.4×-1.7× | 2.6×+0.1× | 2.4×-0.6× | 3.2×-0.2× | |
| Price / book | 2.3×-1.9× | 3.9×-3.4× | 4.3×-0.5× | 4.1×-2.0× | 5.5×— | |
| EV / EBITDA | 8.3×-4.1× | 10.9×-9.6× | 13.7×+2.0× | 14.6×— | 16.6×— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are MiMedx Group's profit margins?
- MiMedx Group (MDXG) runs a 81.0% gross margin and a 10.2% operating margin, with a 7.9% net margin.
- Where do MiMedx Group's ratios come from?
- Every ratio is computed from MiMedx Group's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
